Kevin M. Slawin, Chief Technology Officer at BELLICUM PHARMACEUTICALS, INC (BLCM), sold 4,584 shares at $20.00 ($92K) on 2016-09-20, disclosed to the SEC on 2016-09-20.
Scheduled sale ($92k) by Chief Technology Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.00 | 636 | $13K | 13.9% |
| 2 | $20.00 | 942 | $19K | 20.5% |
| 3 | $20.01 | 1,206 | $24K | 26.3% |
| 4 | $20.02 | 1,400 | $28K | 30.6% |
| 5 | $20.00 | 100 | $2K | 2.2% |
| 6 | $20.00 | 300 |
| $6K |
| 6.5% |
| Total | $20.01 avg | 4,584 | $92K | 100% |
| Filing → |
| BLCM | SELL | 2016-09-23 | $936K | — | Filing → |
| BLCM | SELL | 2016-08-17 | $2.0M | — | Filing → |
| BLCM | SELL | 2016-07-29 | $225K | — | Filing → |